Antiresorptive Consolidation After Osteoanabolic Therapy

This cohort study examines the clinical implementation of timely consolidation with antiresorptive therapy to preserve bone mineral density gains and reduce fracture risk.

Corresponding Authors: Juan P. Brito, MD, MS, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (brito.juan@mayo.edu); Rozalina G. McCoy, MD, MS, Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, 670 W Baltimore St, Baltimore, MD 21201 (rozalina.mccoy@som.umaryland.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.